Proton Pump Inhibitors (PPI) Market
Global Proton Pump Inhibitors (PPI) Market Size, Share & Trends Analysis Report, by Type (Esomeprazole, Omeprazole, Pantoprazole, Dexlansoprazole, Rabeprazole, Lansoprazole and other), by Administration (Over the Counter and Prescription) and Forecast Period, 2020-2026 Update Available - Forecast 2024-2030
The global proton pump inhibitors market is estimated to grow at a CAGR of around 6% during the forecast period. Proton Pump Inhibitors (PPI) is the group of drugs that reduces the risk of gastric acid such as secretion, ulcers and symptoms of gastroesophageal reflux disease in the stomach. Gastroesophageal reflux disease also is known as GERD, is a chronic disease causing problem in the stomach. Additionally, an increase in GERD is due to factors such as tobacco use, obesity and other related problems, this leads to an increase in demand for PPI.
Furthermore, the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma have a higher risk of developing GERD. In this treatment, the medicines are prescribed orally, in the form of tablets and capsules. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand for novel delivery system accelerating the proton pump inhibitors market growth.
Due to large inclination towards over the counter (OTC) drugs, the market share and growth rate is expected to increase. OTC drugs are the medicines sold directly to consumers without any prescription from healthcare professionals. However, several side effects such as headache, dry mouth, nausea, allergy, diarrhea, kidney-related problems and others related to the treatment hamper the market growth. Apart from this, the diversified market share increases the understanding of various bends that leads to an increase in customer acceptance of esomeprazole drugs is one of the opportunity factors for the PPI market. Apart from this, lack of reach in isolated or remote areas and an increase in consumption of generic drugs can hamper the market growth. However, an increase in demand for novel drugs and introducing new products in the market grab the opportunity factor to increase market growth.
Market Segmentation
The global proton pump inhibitors market is segmented based on type and administration. Based on type, the market is classified into esomeprazole, omeprazole, dexlansoprazole, pantoprazole, rabeprazole, lansoprazole and other. Based on administration, the market is classified into OTC and prescription. The global Proton Pump Inhibitors market is growing due to its global acceptance due to various factors such as treatment potential and the availability of global distribution channels across the globe. Nexium is one of the drugs used to treat gastric acid problems such as GERD. After FDA approval on labeling Nexium drug as an OTC drug, the sales and market growth rate increased rapidly. OTC drugs reduce the operation cost by no regular monitoring of the drug. Further, these drugs are sold without a prescription and accelerated the acceptance rate among the population.
Global Proton Pump Inhibitors Market Share by Type, 2019 (%)
Regional Outlook
Geographically, the global proton pump inhibitors market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to hold a considerable market share attributed to an increase in the number of gastrointestinal problems in the US region. Moreover, due to the availability of technological advancement and intensive research & development of PPI drugs leads the manufacturers to increase the production of medicines due to the rise in demand for OTC drugs in the region. Further, due to the continuous production of these drugs and new product launch accelerating the market in the region. However, Asia-Pacific is witnessing huge growth in the PPI market due to the rising demand for gastric drugs such as Nexium to cure the gastrointestinal problem.
Global Proton Pump Inhibitors Market Growth, by Region 2019-2025
Competitive Landscape
The major companies providing PPI include AstraZeneca PLC, Takeda Pharmaceuticals Co. Ltd., Pfizer, Inc., Bayer AG, Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.), Aurobindo Pharma, Ltd., Eisai Co., Ltd., Procter & Gamble Co., and Sanofi S.A. These players adopt various strategies in order to stay competitive in the market and expand their market share. For instance, in March 2020, AstraZeneca launched NEXIUM Direct to provide medication to the eligible patient directly to their home. Where these operations are monitored by certified pharmacy technicians and registered pharmacists, by collaborating with the Eagle pharmacy.
The Report Covers
- Market value data analysis of 2020 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global PPI market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. AstraZeneca PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Takeda Pharmaceuticals Co. Ltd.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Pfizer, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Bayer AG
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.)
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Proton Pump Inhibitors Market by Type
5.1.1. Esomeprazole
5.1.2. Omeprazole
5.1.3. Dexlansoprazole
5.1.4. Pantoprazole
5.1.5. Rabeprazole
5.1.6. Lansoprazole
5.1.7. Other
5.2. Global Proton Pump Inhibitors Market by Administration
5.2.1. Over the Counter
5.2.2. Prescription
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Alkem Laboratories, Ltd.
7.2. AstraZeneca PLC
7.3. Aurobindo Pharma, Ltd.
7.4. Bayer AG
7.5. Cadila Healthcare, Ltd.
7.6. Chongqing LUMMY Pharmaceutical Co., Ltd.
7.7. Eisai Co., Ltd.
7.8. GlaxoSmithKline PLC
7.9. Glenmark Pharmaceuticals, Inc.
7.10. Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
7.11. Lannett Company, Inc.
7.12. Novartis AG
7.13. Pfizer, Inc.
7.14. Procter & Gamble Co.
7.15. Sanofi S.A.
7.16. Sun Pharmaceutical Industries, Ltd.
7.17. Takeda Pharmaceutical Co. Ltd.
7.18. Teva Pharmaceuticals Industries, Ltd.
1. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
2. GLOBAL ESOMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL OMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL DEXLANSOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
5. GLOBAL PANTOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL RABEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL LANSOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
8. GLOBAL OTHER PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
9. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
10. GLOBAL OVER THE COUNTER PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
11. GLOBAL PRESCRIPTION PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
12. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
13. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
14. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
15. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
16. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
17. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
18. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
19. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
20. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
21. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
22. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
23. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
1. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY TYPE, 2019 VS 2026 (%)
2. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY ADMINISTRATION, 2019 VS 2026 (%)
3. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
4. US PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
6. UK PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
7. FRANCE PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
8. GERMANY PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
9. ITALY PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
10. SPAIN PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
11. ROE PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
12. INDIA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
13. CHINA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
14. JAPAN PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
15. REST OF ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
16. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
